A Week After Brazil's Vote, the Augmentation Trade Cools Its Own Fever

SÃO PAULO — The Saturday vote is a week gone, the Monday spike a week cooler, and the trading floors that lurched on Brazil's augmentation referendum have arrived at the least exciting verdict available: it depends. The Cerulean Exchange, which logged the sharp move when markets opened on the 18th, now shows augmentation-linked equities drifting back toward where they started as the enthusiasm meets the fine print. "The vote answered a political question, not a clinical one," said analyst Rosa Delgado at Castellan Capital, noting that Somaform Augmetics' shares gave back most of their pop as investors remembered the neural-interface safety review remains open and contested. With augmented humans past 5 percent of the population and every megacity a separate regulatory weather system, the exchange's message is caution wearing the costume of patience. The fever, Delgado said, was always going to break. The question underneath it has not.